← Every company
Revelation Biosciences Inc SEC Filings
What Revelation Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
REVB overview →Filings on file
106
since Jul 29, 2020
Warning signs
15
latest Jan 7, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jan 7, 2025 | Delisting notice or listing transfer 8-K | Read ↗ |
| Oct 21, 2024 | Delisting notice or listing transfer 8-K | Read ↗ |
| Aug 19, 2024 | Delisting notice or listing transfer 8-K | Read ↗ |
| Aug 11, 2023 | Delisting notice or listing transfer 8-K | Read ↗ |
| May 15, 2023 | Late filing notice NT 10-Q | Read ↗ |
| Dec 12, 2022 | Delisting notice or listing transfer 8-K | Read ↗ |
| Nov 25, 2022 | Delisting notice or listing transfer 8-K | Read ↗ |
| Jun 10, 2022 | Delisting notice or listing transfer 8-K | Read ↗ |
| May 31, 2022 | Delisting notice or listing transfer 8-K | Read ↗ |
| May 6, 2022 | Auditor change 8-K | Read ↗ |
| Mar 31, 2022 | Late filing notice NT 10-K | Read ↗ |
| Aug 17, 2021 | Late filing notice NT 10-Q | Read ↗ |
| Jun 16, 2021 | Earlier accounts withdrawn 8-K | Read ↗ |
| Jun 1, 2021 | Delisting notice or listing transfer 8-K | Read ↗ |
| May 18, 2021 | Late filing notice NT 10-Q | Read ↗ |
Source: Revelation Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.